Shares surge in the public market debuts of Livongo and Health Catalyst
Both Livongo and Health Catalyst held their IPOs today and saw their stock price soar more than 40 percent in early trading.
Aurinia rocks the boat with $150M public offering
Aurinia Pharmaceuticals put cashflow issues behind it on Tuesday, announcing a public offering that it expects will generate $150.5 million in gross proceeds for its Phase 3 trial in lupus nephritis. But not everyone was happy with the news.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.